Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
EQRx (United States)
Alternate names:
EQRx,
EQRx Inc.,
EQRx, Inc.
ROR:
018f3ag52
OpenAlex ID:
I4405270745
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations
2022
·
Shun Lu
, Xiaorong Dong
, et al.
·
Journal of Clinical Oncology
·
342
PDF
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer: A Randomized Clinical Trial
2021
·
Leora Horn
, Ziping Wang
, et al.
·
JAMA Oncology
·
277
PDF
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti–PD-1 Therapy
2021
·
Léa Dousset
, Florence Poizeau
, et al.
·
JCO Precision Oncology
·
73
PDF
Whole brain network effects of subcallosal cingulate deep brain stimulation for treatment-resistant depression
2023
·
Jungho Cha
, Ki Sueng Choi
, et al.
·
Molecular Psychiatry
·
43
PDF
Investigation of Cardioprotective Activity of Silybin: Network Pharmacology, Molecular Docking, and In Vivo Studies
2023
·
Praveen Kumar Pasala
, Madhuri Donakonda
, et al.
·
ChemistrySelect
·
36
Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer
2022
·
Laura M. Spring
, Hyo Han
, et al.
·
Nature Cancer
·
33
PDF
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors
2021
·
Jonathan W. Riess
, Shaila Rahman
, et al.
·
Translational Oncology
·
22
Real-World Association of HER2/ ERBB2 Concordance with Trastuzumab Clinical Benefit in Advanced Esophagogastric Cancer
2021
·
Stacey M Stein
, Jeremy Snider
, et al.
·
Future Oncology
·
18
PDF
Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment
2021
·
Mehmet Akce
, Anthony El-Khoueiry
, et al.
·
Cancer Chemotherapy and Pharmacology
·
18
PDF
The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma
2023
·
Isabelle Ray-Coquard
, Bradley J Monk
, et al.
·
International Journal of Gynecological Cancer
·
16
PDF
In-silico Investigation and Development of Cyclooxygenase-2 (1CX2) Selective Inhibition as a Possible Anti-Inflammatory Activity
2024
·
Ramu Samineni
, Prasanthi Samathoti
, et al.
·
Biomedical & Pharmacology Journal
·
13
Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality
2023
·
Joseph M. Unger
, Hillary Stires
, et al.
·
JCO Oncology Practice
·
11
PDF
Possible cerebroprotective effect of citronellal: molecular docking, MD simulation and in vivo investigations
2023
·
G. Vamshi
, Prasanth D. S. N. B. K.
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
11
Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND
2021
·
Désirée van der Heijde
, Cynthia E. Kartman
, et al.
·
The Journal of Rheumatology
·
11
PDF
Detection of idiopathic normal pressure hydrocephalus on head CT using a deep convolutional neural network
2023
·
Matthew A. Haber
, Giorgio P. Biondetti
, et al.
·
Neural Computing and Applications
·
8
Current approaches to evaluate the function of cytotoxic T-cells in non-human primates
2023
·
Cris Kamperschroer
, Brendon Frank
, et al.
·
Journal of Immunotoxicology
·
6
PDF
Novel Sequential Immunocapture Microflow LC/MS/MS Approach to Measuring PTH-Fc Protein in Human Serum
2021
·
Haixing Wang
, Jiang Wu
, et al.
·
Bioanalysis
·
4
An Overview on Nitrogen-containing Heterocyclic Compounds as Anticancer Agents
2023
·
Anshu R Dudhe
, Sachinkumar D Gunjal
, et al.
·
International Journal of Pharmaceutical Quality Assurance
·
3
PDF
Interference in a Neutralizing Antibody Assay for Odronextamab, a CD20xCD3 Bispecific mAb, from Prior Rituximab Therapy and Possible Mitigation Strategy
2022
·
Susan C. Irvin
, Amanda D’Orvilliers
, et al.
·
The AAPS Journal
·
3
PDF
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial
2025
·
Linda K. Zane
, Laura M. Yee
, et al.
·
Clinical Cancer Research
·
2
Molecular Fingerprints for Robust and Efficient ML-Driven Molecular Generation
2022
·
Tazhigulov, Ruslan N.
, Schiller, Joshua
, et al.
·
arXiv (Cornell University)
·
2
PDF
Semantic Decomposition Improves Learning of Large Language Models on EHR Data
2022
·
Bloore, David A.
, Gauriau, Romane
, et al.
·
arXiv (Cornell University)
·
2
PDF
1005P Indirect treatment comparisons of relative efficacy for aumolertinib vs osimertinib in EGFR-positive non-small cell lung cancer (NSCLC)
2022
·
S. Popat
, S. Stergiopoulos
, et al.
·
Annals of Oncology
·
1
Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer
2022
·
Laura M. Spring
, Hyo Han
, et al.
·
Nature Cancer
·
1
PDF
Impact of the COVID-19 pandemic mitigation strategies on cancer treatment trials: A meta-analysis of industry and NCI studies.
2024
·
Joseph M. Unger
, Hillary Andrews
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
32
Citation count:
1,299
Year
Topic
Type
